Variations in lipid and lipoprotein levels during isotretinoin treatment for acne vulgaris with special emphasis on HDL-cholesterol

International Journal of Dermatology

Volumn 36, Issue 11, 1997, Pages 859-862

  Lestringant, Gilles G ^a,b   Frossard, Philippe M ^a,b   Agarwal, Mukesh ^a,b   Galadari, Ibrahim H ^a,b  

^a TAWAM HOSPITAL   (United Arab Emirates)

^b UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOTRETINOIN; LIPID; LIPOPROTEIN;

ACNE VULGARIS; ADOLESCENT; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CORONARY RISK; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; REMISSION; RISK ASSESSMENT;

EID: 0030829813     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.1997.00331.x     Document Type: Article

References (24)

1. Ebling JFG, Cunliffe WJ. Disorders of the sebaceous glands. In: Champion RH, Burton JL, Ebling FJG, eds. Textbook of Dermatology, 5th edn., Vol. 3. Oxford: Blackwell Scientific Publications, 1991: 1717.
2. Cunliffe WJ, Layton AM. Oral isotretinoin: patient selection and management. J Dermatol Treat 1993; 4(Suppl. 2.): S10-S15.
3. Shalita AR, Armstrong RB, Leyden JJ, et al. Isotretinoin revisited. Cutis 1988; 42: 1-19.
4. Weber-Buisset MJ, Lehucher-Ceyrac D. Isotretinoin and acne in practice: a prospective analysis of 188 cases over 9 years. Dermatology 1993; 186: 113-12.8.
5. Griffiths A, ed. Isotretinoin in acne. J Dermatol Treat 1993; 4(Suppl. 2): S17.
6. Saurat JH. Side effects of systemic retinoids and their clinical management. J Am Acad Dermatol 1992; 27: S23-S28.
7. Windhorst DB, Nigra T. General toxicology of oral retinoids. J Am Acad Dermatol 1982; 6: 675-682.
8. Gollnick H, Schwartzkopff W, Luley C, Orfanos CE. Alterations of lipid metabolism under treatment with oral retinoids (isotretinoin and etretinate). In: Farber EM and Cox AJ, eds. Psoriasis Congress. New York: Grune & Stratton, 1982: 479-486.
9. Zech LA, Gross EG, Peck GL, Brewer HB. Changes in plasma cholesterol and triglyceride levels after treatment with oral isotretinoin. Arch Dermatol 1983; 119: 987-993.
10. Marsden RM, Trinick TR, Laker MF, Shuster S. Effects of isotretinoin on serum lipids and lipoproteins, liver and thyroid function. Clin Chim Acta 1984; 143: 143-251.
11. Vahliquist C, Michaelsson G, Vahliquist A, Vessby B. A sequential comparison of etretinate (Tigason) and isotretinoin (Roaccutane) with special regard to their effects on serum lipoproteins. Br J Dermatol 1985; 112: 69-76.
12. O'Leary TJ, Kanigsberg N, Walker J, et al. The effect of isotretinoin (Accutane) on serum lipids. Clin Invest Medicine 1985; 8: A82.
13. Bershad S, Rubinstein A, Paterniti Jr JR, et al. Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne. N Engl J Med 1985; 313: 981-985.
14. Marsden J. Hyperlipidemia due to isotretinoin and etretinate: possible mechanisms and consequences. Br J Dermatol 1986; 114: 401-407.
15. Laker MF, Green C, Bhuiyan AKMJ, Shuster S. Isotretinoin and serum lipids: studies on fatty acid, apolipoprotein and intermediary metabolism. Br J Dermatol 1987; 117: 2.03-2.06.
16. Marsden JR. Lipd metabolism and retinoid therapy. Pharmacol Therapeutics 1989; 40: 55-65.
17. Walker BR, MacKiie MR. Serum lipid elevation during isotretinoin therapy for acne in the West of Scotland. Br J Dermatol 1990; 122: 531-537.
18. Barth JH, MacDonald-Hull SP, Mark J, et al. Isotretinoin therapy for acne vulgaris: a re-evaluation of the need for measurements of plasma lipids and liver function tests. Br J Dermatol 1993; 129: 704-707.
19. Ostlere LS, Harris D, Morse-Fisher N, Wright S. Effect of systemic administration of isotretinoin on blood lipids and fatty acids in acne patients. Int J Dermatol 1996; 35: 216-221.
20. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clin Chem 1972. 18: 499-502.
21. David M, Hodak E, Lowe NJ. Adverse effects of retinoids. Medical Toxicology 1988; 3: 273-288.
22. Layton AM, Stainforth JM, Cunliffe WJ. Ten years' experience of oral isotretinoin for the treatment of acne vulgaris. J Dermatol Treat 1993; 4(Suppl. 2): 52-85.
23. Shahidullah M, Tham SN, Goh C-L. Isotretinoin therapy in acne vulgaris: a 10 year retrospective study in Singapore. Int J Dermatol 1994; 33: 60-63.
24. Al-Khawajah MM. Isotretinoin for acne vulgaris. Int J Dermatol 1996; 35: 212-215.